Urolog. pro Praxi, 2007; 8(4): 153-156

Prostatic syndrome - syndrome of chronic pelvic pain

MUDr. Kamil Belej FEBU
Urologické oddělení Ústřední vojenská nemocnice, Praha

The Chronic Prostatitis Syndrome (CPS) is defined as a complex of symptoms which may arise in the prostate itself or in neighbouring structures and organs. Syndrome includes pain in the pelvic floor, as implied in the recent NIH classification and condition was named as Chronic Prostatitis – Chronic Pelvic Pain Syndrome (CP/CPPS). It may have different aetiologies and physiopathologic mechanisms making treatment difficult. Additional treatments except antibiotics include alpha-blockers, antiinflammatory agents and many other drugs and various treatment modalities, from prostatic massage and pelvic floor physiotherapy to transurethral resection of the prostate.

Keywords: prostate, pelvic floor, pain

Published: September 7, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Belej K. Prostatic syndrome - syndrome of chronic pelvic pain. Urol. praxi. 2007;8(4):153-156.
Download citation

References

  1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Am J Obstet Gynecol 2002; 187: 116-126. Go to original source... Go to PubMed...
  2. Barsom S et al. Erfolgreiche Prostatitisbehandlung mit hydrolytischen Enzymen. Erfahrungsheilkunde 1982, 31: 2-5.
  3. Bartoníčková K. Infekce močových cest u urologických nemocných. In: Teplan V, Horáčková M, Bébrová E, Janda J, a kol. Infekce ledvin a močových cest v dospělém a dětském věku. Praha, Grada Publishing, 2004; 127-151.
  4. Belej K, Hrabec M, Záťura F. Úloha transrektálnej ultrasonografie v diagnostike mužskej neplodnosti. Klin urol 2006; 3: 167-170.
  5. Blenk H, Hofstetter A. Complement C3, coeruloplasmin and PMN-elastase in the ejaculate in chronic prostatoadnexitis and their diagnostic value. Infection 1991; 19 (Suppl3): 138-140. Go to original source... Go to PubMed...
  6. Cornel EB, van Haarst EP, Schaarsberg RW, Geels J. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005; 47 (5): 607-611. Go to original source... Go to PubMed...
  7. Dorschner W, Biesold M, Schmidt F, Stolzenburg JU. The dispute about the external sphincter and the urogenital diaphragm. J Urol 1999; 162 (6): 1942-1945. Go to original source... Go to PubMed...
  8. Fügner D. Návrat masáže prostaty. Urol pro praxi 2004; 5: 223-225.
  9. Fügner D. Prostatodynie - pohledy odjinud? (část II.). Urol pro praxi 2003; 3: 99-101.
  10. Hochreiter W, Bader P. Ätiopathogenese der Prostatitis. Urologe A 2001; 40: 4-8. Go to original source... Go to PubMed...
  11. Litwin MS, McNaughton-Collins M, Fowler FJ et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 1999; 162: 369-375. Go to original source... Go to PubMed...
  12. Luzzy G, O'Leary M. Chronic pelvic pain syndrome. BMJ 1999; 318: 1227-1228. Go to original source... Go to PubMed...
  13. Marek J a kol. Syndrom kostrče a pánevního dna. Triton, Praha, 2000.
  14. Merskey H, Bogduk N. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP Press 2002.
  15. Messelink B. Urogenital pain in men and the role of the pelic floor. Workshop ICS, 2002.
  16. Naber KG, Bishop MC, Bjerklund-Johansen TE et al. EAU guidelines on the management of urinary and male genital tract infections (update 2006). www.uroweb.nl/files/uploaded_files/ guidelines/15%20Male%20UTI.pdf.
  17. Nickel JC, Ardern D, Downey J. Cytologic evaluation of urine is important in evaluation of chronic prostatitis. Urology. 2002; 60 (2): 225-227. Go to original source... Go to PubMed...
  18. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 2004; 93 (7): 991-995. Go to original source... Go to PubMed...
  19. Nickel JC, Moon T. Chronic bacterial prostatitis: an evolving clinical enigma. Urology 2005; 66: 2-8. Go to original source... Go to PubMed...
  20. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis. consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999; 54: 229-233. Go to original source... Go to PubMed...
  21. Nickel JC, Pontari M, Moon T et al. A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003; 169: 1401-1405. Go to original source... Go to PubMed...
  22. Nickel JC. The three As of chronic prostatitis therapy: antibiotics, a-blockers and anti-inflammatories. What is the evidence? BJU Int 2004; 94: 1230-1233. Go to original source... Go to PubMed...
  23. Pavone-Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part II. EAU-EBU Update Series 2007; 5: 16-25. Go to original source...
  24. Phlogenzym - Summary of product characteristics. MUCOS Pharma GmbH & Co. http://www.sukl.cz/_download/spc/SPC21025.doc.
  25. Propert KJ, Alexander RB, Nickel CJ et al. for the Chronic Prostatitis Collaborative Research Network. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59: 870-876. Go to original source... Go to PubMed...
  26. Shoskes DA, Zeitlin SI. Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate cancer and prostatic diseases 1999; 2: 159-162. Go to original source... Go to PubMed...
  27. Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006; 355: 1690-1698. Go to original source... Go to PubMed...
  28. Skalka P. Možnosti léčebné rehabilitace v léčbě močové inkontinence. Urol pro praxi, 2002; 3: 94-100.
  29. Turner JA, Ciol MA, Korff M, Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol 2003; 169: 580-583. Go to original source... Go to PubMed...
  30. Urban M, Heráček J. Chronické pánevní bolesti. Urol listy 2005; 3 (2), 48-55.
  31. Wobenzym - Summary of product characteristics. MUCOS Pharma GmbH & Co. http://www.sukl.cz/_download/spc/SPC10143.doc.
  32. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE. Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol 2003; 170: 823-827. Go to original source... Go to PubMed...
  33. Zámečník L, Pešl M, Soukup V, Dvořáček J. Sexuální dysfunkce u pacientů s chronickou prostatitidou/syndromem chronické pánevní bolesti. Urol pro praxi 2005; 1: 23-25.
  34. Zermann D. Chronic prostatitis: a myofascial pain syndrome? Infect Urol 1999; 12 (3): 84-88.
  35. Zermann DH, Ishigooka M, Wunderlich H, Reichelt O, Schubert J. A study of pelvic floor function pre- and postradical prostatectomy using clinical neurourological investigations, urodynamics and electromyography. Eur Urol 2000; 37 (1): 72-78. Go to original source... Go to PubMed...
  36. Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA. 2006; 296 (13): 1619-1632. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.